43526 Federal Register / Vol. 71, No. 147 / Tuesday, August 1, 2006 / Notices 

Date, and significant changes, if any, 

that are likely to occur within a 

reasonably foreseeable time. Supply 

conditions to consider include 

technology; production methods; 

development efforts; ability to increase 

production (including the shift of 

production facilities used for other 

products and the use, cost, or 

availability of major inputs into 

production); and factors related to the 

ability to shift supply among different 

national markets (including barriers to 

importation in foreign markets or 

changes in market demand abroad). 

Demand conditions to consider include 

end uses and applications; the existence 

and availability of substitute products; 

and the level of competition among the 

Domestic Like Product produced in the 

United States, Subject Merchandise 

produced in the Subject Countries, and 

such merchandise from other countries. 

(11) (Optional) A statement of 

whether you agree with the above 

definitions of the Domestic Like Product 

and Domestic Industry; if you disagree 

with either or both of these definitions, 

please explain why and provide 

alternative definitions. 

Authority: These reviews are being 

conducted under authority of title VII of the 

Tariff Act of 1930; this notice is published 

pursuant to section 207.61 of the 

Commission’s rules. 

By order of the Commission. 

Issued: July 26, 2006. 

Marilyn R. Abbott, 

Secretary to the Commission. 

[FR Doc. E6–12275 Filed 7–31–06; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[USITC SE–06–048] 

Government in the Sunshine Act 

Meeting Notice 

AGENCY HOLDING THE MEETING: United 

States International Trade Commission. 

TIME AND DATE: August 7, 2006 at 11 a.m. 

PLACE: Room 101, 500 E Street SW., 

Washington, DC 20436, Telephone: 

(202) 205–2000. 

STATUS: Open to the public. 

MATTERS TO BE CONSIDERED: 1. Agenda 

for future meetings: none. 

2. Minutes. 

3. Ratification List. 

4. Inv. No. 731–TA–1104 

(Preliminary) (Certain Polyester Staple 

Fiber from China)—briefing and vote. 

(The Commission is currently scheduled 

to transmit its determination to the 

Secretary of Commerce on August 7, 

2006; Commissioners’ opinions are 

currently scheduled to be transmitted to 

the Secretary of Commerce on or before 

August 14, 2006.). 

5. Outstanding action jackets: none. 

In accordance with Commission 

policy, subject matter listed above, not 

disposed of at the scheduled meeting, 

may be carried over to the agenda of the 

following meeting. 

By order of the Commission. 

Issued: July 27, 2006. 

Marilyn R. Abbott, 

Secretary to the Commission. 

[FR Doc. 06–6644 Filed 7–28–06; 1:12 pm] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Application 

Prior to issuing a registration under 21 

U.S.C. 952(a)(2)(B), and in accordance 

with 21 CFR 1301.34(a), this is notice 

that on April 13, 2005, Kenco VPI, 

Division of Kenco Group Inc., 350 

Corporate Place, Chattanooga, TN 

37419, has made application to the Drug 

Enforcement Administration (DEA) by 

letter to be registered as an importer of 

Nabilone (7379), a basic class of 

controlled substance listed in Schedule 

II. 

The company plans to import the 

listed controlled substance for 

distribution to its customers. 

Kenco VPI has been an importer of 

Schedule III–V controlled substances 

since June 14, 2004. On April 14, 2005, 

the DEA added Schedule II to the firm’s 

importer registration. The DEA also 

added the drug code for Nabilone, a 

Schedule II controlled substance, to the 

firm’s registration on April 28, 2005. 

Both amendments to the registration 

were made without benefit of the 

required legal process for modifying the 

DEA registration. Kenco VPI is currently 

complying with the legal requirements 

to register as a Schedule III importer. In 

addition the firm was given 

authorization to import the Nabilone 

product into the United States on May 

12, 2005. The Nabilone product was 

approved by the Food & Drug 

Administration on May 15, 2006. DEA 

has agreed to allow Kenco VPI to 

continue to import the Nabilone product 

into the United States, while the firm is 

completing the required legal process. 

Any manufacturer who on April 13, 

2005, was registered, or applying to be 

registered with DEA to manufacture 

such basic class of controlled substance 

may file comments or objections to the 

issuance of the proposed registration 

and may, at the same time, file a written 

request for a hearing on such 

application pursuant to 21 CFR 1301.43 

and in such form as prescribed by 21 

CFR 1316.47. For purposes of this 

Notice, DEA has chosen recognized 

applicable manufacturers registered on 

April 13, 2005, the date on which Kenco 

submitted its initial request to have 

Nabilone added to its DEA importer 

registration. By employing this date, 

DEA seeks to equitably address its 

initial failure to publish Kenco’s request 

to import Nabilone, while at the same 

time allowing those entities that would 

have been in a position to request a 

hearing on April 13, 2005, had DEA 

filed a timely notice, the right to request 

a hearing. 

Any such written comments or 

objections being sent via regular mail 

may be addressed, in quintuplicate, to 

the Deputy Assistant Administrator, 

Office of Diversion Control, Drug 

Enforcement Administration, 

Washington, DC 20537, Attention: DEA 

Federal Register Representative/ODL; or 

any being sent via express mail should 

be sent to DEA Headquarters, Attention: 

DEA Federal Register Representative/ 

ODL, 2401 Jefferson-Davis Highway, 

Alexandria, Virginia 22301; and must be 

filed no later than August 31, 2006. 

This procedure is to be conducted 

simultaneously with and independent 

of the procedures described in 21 CFR 

1301.34(b), (c), (d), (e), and (f). As noted 

in a previous notice published in the 

Federal Register on September 23, 1975, 

(40 FR 43745–46), all applicants for 

registration to import a basic class of 

any controlled substance listed in 

Schedule I or II are, and will continue 

to be, required to demonstrate to the 

Deputy Assistant Administrator, Office 

of Diversion Control, Drug Enforcement 

Administration, that the requirements 

for such registration pursuant to 21 

U.S.C. 958(a), 21 U.S.C. 823(a), and 21 

CFR 1301.34(b), (c), (d), (e), and (f) are 

satisfied. 

Dated: July 26, 2006. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E6–12256 Filed 7–31–06; 8:45 am] 

BILLING CODE 4410–09–P 


rwilkins on PROD1PC63 with NOTICES